Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Lumicell, Inc.

News headline image
Lumicell’s Board of Directors Appoints Howard Hechler as Chief Executive Officer
From Lumicell, Inc.
Via Business Wire
News headline image
Lumicell’s LumiSystem™ Featured on Viewpoint with Dennis Quaid for New Episode on Fluorescence-Imaging Guidance During Lumpectomy Surgery
From Lumicell, Inc.
Via Business Wire
News headline image
Lumicell Awarded Phase I NIH SBIR Contract to Develop Novel Flexible Endoscope for Fluorescence Imaging of LUMISIGHT™ to Detect Early Esophageal Lesions in Patients with Barrett’s Esophagus
From Lumicell, Inc.
Via Business Wire
News headline image
CMS Grants Transitional Pass-Through Payment for LUMISIGHT™ (pegulicianine) and Increases Access for Patients with Breast Cancer
From Lumicell, Inc.
Via Business Wire
News headline image
Lumicell Announces New Category III CPT® Code for Intraoperative Fluorescence Imaging Margin Assessment in Support of Market Launch
From Lumicell, Inc.
Via Business Wire
News headline image
Lumicell’s Cutting-Edge Imaging Platform Receives Historic FDA Approval to Illuminate Residual Breast Cancer
From Lumicell, Inc.
Via Business Wire
News headline image
Lumicell Announces Initial Data Demonstrating LUMISIGHT™’s Ability to Detect Tumors Metastasized to Multiple Organs in the Peritoneum
From Lumicell, Inc.
Via Business Wire
News headline image
Lumicell Co-Founder Moungi Bawendi Awarded Nobel Prize in Chemistry
From Lumicell, Inc.
Via Business Wire
News headline image
Lumicell Announces FDA Acceptance and Priority Review of New Drug Application for LUMISIGHT™ Optical Imaging Agent for Breast Cancer
From Lumicell, Inc.
Via Business Wire
News headline image
Lumicell™ DVS Pivotal Trial Results Published in NEJM Evidence and to Be Presented at ASBrS Assess Safety and Effectiveness of System for Identifying Residual Breast Cancer During Lumpectomy
From Lumicell, Inc.
Via Business Wire
News headline image
Lumicell™ Direct Visualization System Premarket Approval Application Submitted to U.S. FDA for Intraoperative Breast Cancer Detection and Removal
From Lumicell, Inc.
Via Business Wire
News headline image
Lumicell Submits New Drug Application for LUMISIGHT™ Optical Imaging Agent to U.S. FDA for Intraoperative Breast Cancer Detection and Removal
From Lumicell, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.